SCHEMBL29471148

SCHEMBL29471148

CONC(=O)COc1cc(N2CCN(C)c3cc(-c4cnn(C)c4)ccc32)c2cc(C)c(=O)n(C)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CREBBP Q92793 2/20 0.37
▸ BRD4 O60885 1/20 0.35
▸ GSK3B P49841 13/20 0.35
▸ DYRK1A Q13627 13/20 0.35
▸ WNT1 P04628 11/20 0.35
▸ MAPK8 P45983 1/20 0.34
▸ PRKAB2 O43741 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ CSF1R P07333 1/20 0.33
▸ LYN P07948 1/20 0.33
▸ TGFBR1 P36897 1/20 0.33
▸ TGFBR2 P37173 1/20 0.33
▸ PRKAG1 P54619 1/20 0.33
▸ SIK1 P57059 1/20 0.33
▸ PRKAA1 Q13131 1/20 0.33
▸ SIK2 Q9H0K1 1/20 0.33
▸ SIK3 Q9Y2K2 1/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ FGFR1 P11362 1/20 0.33
▸ FGFR2 P21802 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24316675 1.00 CREBBP (0.37) CREBBPBRD4GSK3BDYRK1AWNT1
SCHEMBL29471161 0.91 BRD4 (0.37) CREBBPBRD4GSK3BDYRK1AWNT1
SCHEMBL24316676 0.91 BRD4 (0.37) CREBBPBRD4GSK3BDYRK1AWNT1
SCHEMBL29471198 0.87 GSK3B (0.38) CREBBPBRD4GSK3BDYRK1AWNT1
SCHEMBL26548496 0.87 GSK3B (0.38) CREBBPBRD4GSK3BDYRK1AWNT1
SCHEMBL24316610 0.83 FGFR1 (0.40) CREBBPBRD4FGFR1FGFR2FGFR3
SCHEMBL26113389 0.76 CREBBP (0.36) CREBBPPIK3CDFGFR3
SCHEMBL30480849 0.76 CREBBP (0.36) CREBBPPIK3CDFGFR3
SCHEMBL24316696 0.75 FGFR1 (0.43) CREBBPFGFR1FGFR2FGFR3
SCHEMBL29471176 0.75 FGFR1 (0.43) CREBBPFGFR1FGFR2FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4210683-A1 HETEROCYCLIC COMPOUNDS AS CBP/EP300 BROMODOMAIN INHIBITORS Aurigene Oncology Limited (IN) 2023-07-19 — — EP disclosed
CN-116368128-A Heterocyclic compounds as CBP/EP300 bromodomain inhibitors 奥瑞基尼肿瘤有限公司 2023-06-30 — — CN disclosed
WO-2022053967-A1 HETEROCYCLIC COMPOUNDS AS CBP/EP300 BROMODOMAIN INHIBITORS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2022-03-17 — — WO disclosed
Send feedback